2012-11-07T17:24:48-06:00 2012-06-30 930900579 MCDONALD JACOBS PC 520 SW YAMHILL STE 500 PORTLAND OR 97204 990 2011-07-01 930571472 NATIONAL PSORIASIS FOUNDATION NATI 5032447404 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 RANDY BERANEK 5032447404 2012-11-06 1 SANG AHN P00540880 5032270581 2011 2016-02-25 16:41:14Z RANDY BERANEK 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 9242617 0 X WWW.PSORIASIS.ORG X 1968 OR TO FIND A CURE FOR PSORIASIS AND PSORIATIC ARTHRITIS AND TO ELIMINATE THEIR DEVASTATING EFFECTS THROUGH RESEARCH, ADVOCACY AND EDUCATION. 16 16 52 8508 703922 0 6190828 8320465 872398 820067 82299 82622 -97470 -262042 7048055 8961112 1152121 1661989 0 0 3037359 3495676 0 25820 1109673 2741528 2485734 6931008 7669219 117047 1291893 6276884 7453451 500879 367661 5776005 7085790 X TO FIND A CURE FOR PSORIASIS AND PSORIATIC ARTHRITIS AND TO ELIMINATE THEIR DEVASTATING EFFECTS THROUGH RESEARCH, ADVOCACY, AND EDUCATION. 0 0 2568088 17874 EDUCATION, OUTREACH, AND PATIENT SERVICES:PROVIDED COMPREHENSIVE RESOURCES AT WWW.PSORIASIS.ORG AND OTHER SITES FOR MORE THAN 2 MILLION VISITORS, INCLUDING MORE THAN 800,000 WHO CONNECTED THROUGH OUR ONLINE COMMUNITIES AND SOCIAL MEDIA.PUBLISHED INFORMATION ON LIVING WELL WITH PSORIATIC DISEASES, AS WELL AS THE LATEST SCIENCE AND TREATMENT UPDATES FOR SOME 165,000 READERS OF PSORIASIS ADVANCE MAGAZINE AND OTHER PRINT PUBLICATIONS.SENT EDUCATIONAL E-NEWSLETTERS TO MORE THAN 200,000 SUBSCRIBERS.HOSTED 22 MORE THAN SKIN DEEP EDUCATIONAL EVENTS, ATTRACTING MORE THAN 1,000 PARTICIPANTS.PRODUCED SIX WEBINARS TO PROVIDE NEARLY 4,000 VIEWERS WITH DETAILED INFORMATION FROM LEADING EXPERTS ON SPECIFIC ASPECTS OF PSORIATIC DISEASES.PROVIDED SUPPORT AND INFORMATION FOR NEARLY 3,500 THROUGH ONE TO ONE MENTOR PROGRAM AND DIRECT RESPONSES TO INDIVIDUAL REQUESTS FOR INFORMATION ON HEALTH, TREATMENT, INSURANCE AND OTHER ISSUES. 2744321 1363329 111045 RESEARCH AND PROFESSIONAL EDUCATION:ANNOUNCED 26 GRANT AWARDS TO DIRECTLY FUND CUTTING-EDGE RESEARCH: EIGHT ONE-YEAR DISCOVERY GRANTS; SIX TWO-YEAR TRANSLATIONAL GRANTS; AND 12 ONE-YEAR RESEARCH FELLOWSHIPS--TOTALING MORE THAN $2 MILLION.SAW SUCCESS FROM PREVIOUS YEARS' GRANTS AS RECIPIENTS PUBLISHED GROUND-BREAKING RESULTS OF FOUNDATION-FUNDED RESEARCH AND EARNED GRANTS FROM THE NATIONAL INSTITUTES OF HEALTH TO CONTINUE THEIR STUDIES.SURPASSED A TOTAL 2,300 DNA SAMPLES COLLECTED FOR THE NATIONAL PSORIASIS VICTOR HENSCHEL BIOBANK, THE PRIMARY SOURCE OF GENETIC MATERIAL FOR PSORIATIC DISEASE RESEARCHERS.PUBLISHED PSORIASIS FORUM, A PEER-REVIEWED MEDICAL JOURNAL, TO PROVIDE APPROXIMATELY 6,000 RHEUMATOLOGISTS, DERMATOLOGISTS AND OTHER MEDICAL PROFESSIONALS WITH THE LATEST RESEARCH AND TREATMENT INFORMATION.HOSTED A CONFERENCE TO BRING LEADING PSORIASIS RESEARCHERS AND CLINICIANS TOGETHER TO SHARE THEIR KNOWLEDGE WITH MORE THAN 100 DERMATOLOGY RESIDENTS. 842543 ADVOCACY AND GOVERNMENT RELATIONS:ADVOCATES SENT MORE THAN 5,000 LETTERS AND HELD CLOSE TO 200 MEETINGS WITH ELECTED OFFICIALS, POLICY MAKERS AND INSURANCE COMPANIES.ACHIEVED IMPROVED ACCESS TO CARE FOR APPROXIMATELY 225,000 HEALTH PLAN SUBSCRIBERS WITH PSORIATIC DISEASES. THIS WORK INCLUDES THE FOUNDATIONS UNIQUELY DIRECT APPROACH WITH INSURANCE COMPANIES. AFTER FOUNDATION ADVOCATES EXPLAINED THE ADVERSE EFFECTS OF CERTAIN RULES, FOUR MAJOR INSURERS VOLUNTARILY MADE SUGGESTED CHANGES IN 2012.BROUGHT NEARLY 30 ADVOCATES AND TOP RESEARCHERS TO THE WASHINGTON, D.C., OFFICES OF 25 SENATORS AND 34 REPRESENTATIVES, ACHIEVING BIPARTISAN SUPPORT AND REINTRODUCTION OF A BILL TO ADD PSORIATIC DISEASES TO THOSE ALREADY IN THE CENTERS FOR DISEASE CONTROL AND PREVENTION SURVEYS AND DATA COLLECTION. PROFESSIONAL EDUCATION PROGRAMS DESIGNED TO IMPROVE THE DELIVERY OF PSORIASIS CARE BY HEALTH PROFESSIONALS. THE FOUNDATION'S PROGRAMS INCLUDE PSORIASIS FORUM NEWSLETTER AND EXHIBITS AT PROFESSIONAL CONVENTIONS. 6154952 1 1 0 1 0 0 0 0 0 1 1 0 0 0 0 0 1 0 0 0 1 1 0 1 1 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 36 0 52 1 1 1 0 0 0 0 1 1 0 0 0 0 X 16 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X X BETTE DRAKE 5032447404 6600 SW 92ND AVENUE NO 300 PORTLAND OR 97223 DANIEL E FARRINGTON 1.00 X X 0 0 0 KRISTA KELLOGG 1.00 X X 0 0 0 MARK S LILLIE 1.00 X X 0 0 0 CHIP NEWTON 1.00 X X 0 0 0 ERIC KIMBLE 1.00 X X 0 0 0 RICK SEIDEN 1.00 X X 0 0 0 STEVE BISHKOFF 1.00 X 0 0 0 COLBY EVANS MD 1.00 X 0 0 0 KATHLEEN GALLANT 1.00 X 0 0 0 LAWRENCE GREEN MD 1.00 X 0 0 0 HOLLY FIELDS KRAFSUR 1.00 X 0 0 0 SARAH KURTS PA-C 1.00 X 0 0 0 MIKE LAUB 1.00 X 0 0 0 MARK LEBWOHL MD 1.00 X 0 0 0 PETE REDDING 1.00 X 0 0 0 TERRI THEISEN 1.00 X 0 0 0 RANDY BERANEK 40.00 X 223238 0 20547 WILLIAM CARDAMON 40.00 X 203597 0 16275 BRUCE BEBO JR 40.00 X 104957 0 14672 SHEILA RITTENBERG 40.00 X 107830 0 17981 639622 0 69475 4 0 1 0 DRINKER BIDDLE REATH LLP ONE LOGAN SQUARE SUITE 2000 PHILIDELPHIA PA 19103 CONSULTING 218810 GENETIC ALLIANCE 4301 CONNECTICUT AVE NW SUITE 404 WASHINGTON DC 20008 BIO-BANK 156016 INTEGRATED PUBLISHING SALES LLC 519 SPICEBUSH LANE CHAGRIN FALLS OH 44023 CONSULTING 124245 ROYLE PRINTING CO 745 S BIRD STREET SUN PRAIRIE WI 53590 PRINTING 111875 4 80257 2309905 5930303 192633 8320465 ADVERTISING INCOME 541800 703922 703922 FEES FROM SURVEY PANEL 561000 96500 96500 SAMPLE FEES 711300 13895 13895 EDUCATION CONFERENCES 611710 5100 5100 CONFERENCE REGISTRATIO 611710 650 650 820067 82622 82622 0 2309905 274887 -274887 -274887 19392 6618 12774 12774 MISCELLANEOUS 900099 71 71 71 8961112 128919 703922 -192194 1363329 1363329 298660 298660 280474 214282 16604 49588 2553770 1951081 151267 451422 102615 78398 6075 18142 325950 249028 19307 57615 232867 177910 13793 41164 26021 18207 1543 6271 182753 182753 25820 25820 608807 516805 48487 43515 682938 467463 31192 184283 276451 211209 16374 48868 264885 142613 58563 63709 227912 188519 35402 3991 30000 22920 1777 5303 33977 25959 2012 6006 SPECIAL EVENTS 83549 83549 DUES & SUBSCRIPTIONS 24065 12448 1234 10383 EVENT EXPENSES 17873 17873 REPORTING & FILING FEES 10098 7715 598 1785 16405 7780 366 8259 7669219 6154952 404594 1109673 X 210245 135798 0 74447 2141289 995915 2712006 1109457 968614 213850 172777 20186 25290 176533 92854 548800 510722 52174 38078 2563395 2420519 0 27398 6276884 7453451 476786 348291 24093 19370 500879 367661 X 4285183 5223157 1490822 1862633 5776005 7085790 6276884 7453451 X 1291893 17892 X X 0 1 1 X 0 X 3929185 4497080 5509700 6190828 8320464 28447257 3929185 4497080 5509700 6190828 8320464 28447257 10272653 18174604 230259 112826 73409 82130 82622 581246 29028503 0.62610 0.64400 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 18016 336952 354968 6204577 6559545 477977 119494 0 0 407047 472758 496550 477977 1854332 2781498 374716 347625 456996 354968 1534305 101762 118190 124138 119494 463584 695376 11521 11906 13135 18016 54578 2578880 1872185 72190 90000 4433255 2193590 288450 202725 105885 2578880 431146 1749437 13007 2193590 428946 3259 1059 431146 1.00000 0.00000 0.00000 1 0 12898 9155 3743 535902 501567 34335 38078 8961112 7669219 1291893 17892 17892 1309785 8985621 17892 6618 24510 8961111 0 8961111 7675836 6618 6618 7669218 0 7669218 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: THE ENDOWMENT WILL BE USED FOR SUPPORT OF THE ORGANIZATION'S EXEMPT PURPOSE, LIMITED TO FIVE PERCENT OF PRINCIPAL PER YEAR, AS WELL AS SUBJECT TO APPROVAL. PART XII, LINE 2D - OTHER ADJUSTMENTS: COST OF SALES 6,618. PART XIII, LINE 2D - OTHER ADJUSTMENTS: COST OF SALES 6,618. 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS RESEARCH 298660 0 0 0 0 0 0 298660 0 298660 EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 48660 CHECK COST EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 50000 CHECK COST EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 100000 CHECK COST EUROPE (INCLUDING ICELAND & GREENLAND) RESEARCH 100000 CHECK COST 0 4 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND FISCAL PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE CHIEF SCIENCE AND MEDICAL OFFICER OF THE NATIONAL PSORIASIS FOUNDATION. X X X X X X 1 HARRIS CONNECT LLC 1511 ROUTE 22 SUITE C-25 BREWSTER NY 10509 FALL/HOLIDAY PHONE CAMPAIGN 0 113141 20000 93141 ARIA COMMUNICATIONS 717 WEST ST GERMAIN STREET ST CLOUD MN 56301 12 MONTH PHONE CAMPAIGN BEGINNING MAY 2012, ENDING APRIL 201 0 12710 5820 6890 125851 25820 100031 AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY WALK FOR A CURE 1336006 1336006 36562 8994 51758 COMMIT TO CURE GALA 973899 973899 34210 109009 13860 20493 2309905 2309905 70772 109009 22854 72251 274886 -274886 1 THE ROCKEFELLER UNIVERSITY 1230 YORK AVE BOX 178 NEW YORK NY 10065 131624158 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS CASE WESTERN RESERVE UNIVERSITY CWRU 10900 EUCLID AVE CLEVELAND OH 44106 341018992 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS HOSPITAL FOR SPECIAL SURGERY 5335 EAST 70TH STREET NEW YORK NY 10021 136714749 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS THE PENNSYLVANIA STATE UNIVERSITY 201 LIFE SCIENCES BLD UNIVERSITY PARK PA 16802 246000376 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVERSITY OF PENNSYLVANIA 816 PENN TOWER 1 CONVENTION AVE PHILADELPHIA PA 19104 231352685 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS NYU SCHOOL OF MEDICINE 540 1ST AVE NEW YORK NY 10016 135562308 501(C)(3) 50000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS MEDICAL COLLEGE OF WISCONSIN FEC 4100 9200 W WISCONSIN AVE MILWAUKEE WI 53226 390806261 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS THE REGENTS OF THE UNIVERSITY OF MICHIGAN 1301 E CATHERINE ST ANN ARBOR MI 48109 386006309 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS WASHINGTON UNIVERSITY 4566 SCOTT AVENUE ST LOUIS MO 63110 430653611 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVESITY OF LOUISVILLE SCHOOL OF MEDICINE 505 S HANCOCK STREET LOUISVILLE KY 40202 611029626 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS BAYLOR RESEARCH INSTITUTE 1950 N STEMMONS FREEWAY SUITE 5010 DALLAS TX 75207 751921898 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS STANFORD UNIVERSITY SCHOOL OF MEDICINE 269 CAMPUS DR ROOM 2145A STANFORD CA 94305 941156365 501(C)(3) 100000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVERSITY OF PENNSYLVANIA 3451 WALNUT ST RM P-221 PHILADELPHIA PA 19104 231352685 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS THE BRIGHAM & WOMEN'S HOSPITAL INC 75 FRANCIS ST BOSTON MA 02115 042312909 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVERSITY OF UTAH 30 N 1900 E 4A330 SCHOOL OF MEDICINE SALT LAKE CITY UT 84132 876000525 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS MASSACHUSETTS GENERAL HOSPITAL 5 FRUIT ST BAR-6 BOSTON MA 02112 041564655 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS RADY CHILDREN'S HOSPITALUNIVERSITY OF CALIFORNIA SAN DIEGO 9500 GILMAN DR LA JOLLA CA 92093 956006144 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS TUFTS MEDICAL CENTER 800 WASHINGTON ST BOX 817 BOSTON MA 02111 043400617 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS WAKE FOREST UNIVERSITY HEALTH SCIENCES MEDICAL CENTER BLVD WINSTONSALEM NC 27157 223849199 501(C)(3) 24500 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVERSITY HOSPITALS OF CLEVELAND PO BOX 74420 CLEVELAND OH 44194 341567805 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS BAYLOR RESEARCH INSTITUTE 3434 LIVE OAK ST 125 DALLAS TX 75204 751921898 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS NORTHWESTERN UNIVERSITY 750 N LAKE SHORE DR 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS UNIVERSITY OF CALIFORNIA SAN FRANCISCO 2200 POST ST C-130-BPX 1214 SAN FRANCISCO CA 94143 946036493 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS MOUNT SINAI SCHOOL OF MEDICINE ONE GUSTAVE L LEVY PLACE BOX 1048 NEW YORK NY 10029 136171197 501(C)(3) 40000 RESEARCH IN ORDER TO IMPROVE DIAGNOSIS AND TREATMENT, AND EVENTUALLY CURE PSORIASIS 24 0 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: GRANT RECIPIENTS WITH MULTI-YEAR AWARDS PROVIDE INTERIM SCIENTIFIC AND FISCAL PROGRESS REPORTS. ALL GRANT RECIPIENTS PROVIDE A FINAL SCIENTIFIC REPORT AND ACCOUNTING AT THE CONCLUSION OF THE RESEARCH TERM. THE INTERIM AND FINAL REPORTS ARE REVIEWED BY THE CHIEF SCIENCE AND MEDICAL OFFICER OF THE NATIONAL PSORIASIS FOUNDATION. X X 0 0 0 0 0 0 0 0 0 RANDY BERANEK 213238 0 10000 0 0 0 10865 0 9682 0 243785 0 0 0 WILLIAM CARDAMON 185242 0 18355 0 0 0 9262 0 7013 0 219872 0 0 0 X 10 154433 SELLING PRICE X AUCTION ITEMS 8 38200 SELLING PRICE 0 1 1 THIRD PARTY USE: PART I, LINE 32B: THE ORGANIZATION USES AN OUTSIDE COMPANY THAT RECEIVES DONATED AUTOMOBILES AND SELLS THEM ON BEHALF OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 1 THE EXECUTIVE COMMITTEE IS COMPRISED OF FIVE VOTING MEMBERS CONSISTING OF THE CHAIR, CHAIR-ELECT, VICE-CHAIR,SECRETARY, AND THE TREASURER. IS HAS THE AUTHORITY AND RESPONSIBLITY TO ACT IN ALL RESPECTS FOR THE BOARD AND IN THE OPERATION OF THE FOUNDATION. FORM 990, PART VI, SECTION B, LINE 11 A COMPLETE COPY OF THE FORM 990 IS E MAILED TO ALL TRUSTEES PRIOR TO BEING FILED ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS SIGNED BY ALL TRUSTEES ANNUALLY. ALL TRUSTEES AND KEY EMPLOYEES REFRAIN FROM VOTING OR COMMENTING ON ANYTHING WHERE THERE COULD BE A CONFLICT. FORM 990, PART VI, SECTION B, LINE 15 THE BOARD OF TRUSTEES ANNUALLY REVIEWS AND APPROVES THE CEO'S COMPENSATION AND PERFORMANCE. THE FOUNDATION UTILIZES AN INDEPENDENT COMPENSATION CONSULTANT AND SUBSCRIBES TO A SALARY SURVEY FOR COMPARABLE INFORMATION FOR SALARIES. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FINANCIAL STATEMENTS ARE ALSO DISPLAYED ON THE WEBSITE. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 17,892. FORM 990, PART XII, LINE 2C: THE PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.